{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:33:25Z","timestamp":1791318805926,"version":"4.3.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.jconrel.2004.09.014","type":"journal-article","created":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T22:58:50Z","timestamp":1102633130000},"page":"85-99","source":"Crossref","is-referenced-by-count":168,"title":["Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery"],"prefix":"10.1016","volume":"102","author":[{"given":"Carrie S.W.","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl P.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Addison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Lorne","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2004.09.014_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-2008-1040517","article-title":"Treatment of chronic hepatitis with interferon: experience in Western countries","volume":"9","author":"Perrillo","year":"1989","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jconrel.2004.09.014_bib2","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/sj.onc.1201444","article-title":"Repression of hepatitis B virus (HBV) transgene and HBV-induced liver injury by low protein diet","volume":"15","author":"Hu","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2004.09.014_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/147.2.185","article-title":"Postnatal infectivity of hepatitis B surface antigen-carrier mothers","volume":"1983","author":"Beasley","year":"1983","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2004.09.014_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM197504102921503","article-title":"Vertical transmission of hepatitis B antigen in Taiwan","volume":"292","author":"Stevens","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2004.09.014_bib5","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.4049\/jimmunol.161.11.5842","article-title":"Polyclonality and multispecificity of the CTL response to a single viral epitope","volume":"161","author":"Ishikawa","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib6","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2004.09.014_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0167-5699(99)01472-3","article-title":"T cell clonality in immune responses","volume":"20","author":"Maini","year":"1999","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jconrel.2004.09.014_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI118592","article-title":"Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection","volume":"97","author":"Rehermann","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2004.09.014_bib9","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI3731","article-title":"Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B","volume":"102","author":"Boni","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2004.09.014_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00192679","article-title":"The cellular immune response to nucleocapsid antigens in hepatitis B virus infection","volume":"12","author":"Mondelli","year":"1990","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib11","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/329547a0","article-title":"Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site","volume":"329","author":"Milich","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2004.09.014_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0676.1998.tb00825.x","article-title":"Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B","volume":"18","author":"Lohr","year":"1998","journal-title":"Liver"},{"key":"10.1016\/j.jconrel.2004.09.014_bib14","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1128\/JVI.75.11.5036-5042.2001","article-title":"Coadministration of gamma interferon with DNA vaccine expressing Woodchuck Hepatitis Virus (WHV) core antigen enhances the specific immune response and protects against WHV infection","volume":"75","author":"Siegel","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1053\/gast.2002.31887","article-title":"Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen","volume":"122","author":"Lau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2004.09.014_bib16","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"Webster","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib17","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/hep.510250438","article-title":"Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B","volume":"25","author":"Penna","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2004.09.014_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-200241070-00003","article-title":"Clinical pharmacokinetics of depot leuprorelin","volume":"41","author":"Periti","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2004.09.014_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v12.i1.10","article-title":"Biodegradable microspheres in drug delivery","volume":"12","author":"Okada","year":"1995","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.jconrel.2004.09.014_bib20","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0264-410X(02)00521-2","article-title":"Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro","volume":"21","author":"Audran","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0264-410X(02)00531-5","article-title":"Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro","volume":"21","author":"Sun","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib22","first-page":"259","article-title":"Modulation of the immune response to tetanus toxoid by polylactide\u2013polyglycolide microspheres","volume":"92","author":"Walker","year":"1998","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.jconrel.2004.09.014_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-5173(02)00342-3","article-title":"Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants","volume":"245","author":"Raghuvanshi","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.09.014_bib24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jps.10042","article-title":"Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres","volume":"91","author":"Shi","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.09.014_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(01)00957-7","article-title":"Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice","volume":"234","author":"Jung","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.09.014_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/meth.1999.0834","article-title":"Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines","volume":"19","author":"Baldridge","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2004.09.014_bib27","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/S0264-410X(99)00062-6","article-title":"The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1","volume":"17","author":"Moore","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4615-1823-5_21","article-title":"Monophosphoryl lipid A as an adjuvant. Past experiences and new directions","volume":"6","author":"Ulrich","year":"1995","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib29","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1023\/A:1011904627929","article-title":"Microencapsulation of hepatitis B core antigen for vaccine preparation","volume":"15","author":"Uchida","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2004.09.014_bib30","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0960-894X(02)00362-1","article-title":"Lipid A structures containing novel lipid moieties: synthesis and adjuvant properties","volume":"12","author":"Jiang","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2004.09.014_bib31","first-page":"1423","article-title":"Synthetic vaccines: the role of adjuvants in immune targeting","volume":"vol. 10","author":"Jiang","year":"2003"},{"key":"10.1016\/j.jconrel.2004.09.014_bib32","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1016\/S0040-4020(02)01067-0","article-title":"Novel lipid A mimetics derived from pentaerythritol: synthesis and their potent agonistic activity","volume":"58","author":"Jiang","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jconrel.2004.09.014_bib33","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1248\/cpb.36.1095","article-title":"A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic\/glycolic) acid","volume":"36","author":"Ogawa","year":"1988","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.jconrel.2004.09.014_bib34","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1023\/A:1015948829632","article-title":"Release of human serum albumin from poly(lactide-co-glycolide) microspheres","volume":"7","author":"Hora","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2004.09.014_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0264-410X(93)90387-D","article-title":"Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles","volume":"11","author":"O'Hagan","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0021-9673(97)00041-1","article-title":"Analysis of a monophosphoryl lipid A immunostimulant preparation from Salmonella minnesota R595 by high-performance liquid chromatography","volume":"767","author":"Hagen","year":"1997","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.jconrel.2004.09.014_bib37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0006-291X(78)91322-0","article-title":"Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril","volume":"80","author":"Fraker","year":"1978","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2004.09.014_bib38","series-title":"Immunological Techniques Made Easy","author":"Cochet","year":"1998"},{"key":"10.1016\/j.jconrel.2004.09.014_bib39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0003-2697(92)90248-6","article-title":"Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content","volume":"204","author":"Morton","year":"1992","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2004.09.014_bib40","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1023\/A:1018942118148","article-title":"Determinants of release rate of tetanus vaccine from polyester microspheres","volume":"10","author":"Alonso","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2004.09.014_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10426500290095557","article-title":"Correlation between in vitro release and in vivo immune response from biodegradable polymer particles entrapping tetanus toxoid","volume":"9","author":"Raghuvanshi","year":"2002","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2004.09.014_bib42","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/JVI.71.3.2192-2201.1997","article-title":"The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype","volume":"71","author":"Milich","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib43","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0264-410X(95)00184-3","article-title":"Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells","volume":"13","author":"Moore","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib44","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/0264-410X(95)00084-E","article-title":"Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles","volume":"13","author":"Vordermeier","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib45","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(d,l-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2004.09.014_bib46","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1023\/A:1020452531828","article-title":"Analysis of poly(d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro","volume":"19","author":"Lutsiak","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2004.09.014_bib47","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0264-410X(96)00099-0","article-title":"Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity","volume":"14","author":"Nixon","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4049\/jimmunol.163.3.1205","article-title":"Peptide dose, affinity, and time of differentiation can contribute to the Th1\/Th2 cytokine balance","volume":"163","author":"Rogers","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib49","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.4049\/jimmunol.164.8.4037","article-title":"Repeated intratracheal challenge with particulate antigen modulates murine lung cytokines: 2.","volume":"164","author":"Todt","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-3659(97)00142-9","article-title":"Ovalbumin peptide encapsulated in poly(d,l-lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response","volume":"54","author":"Newman","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2004.09.014_bib51","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1021\/js980070s","article-title":"Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses","volume":"87","author":"Newman","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2004.09.014_bib52","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0264-410X(98)00372-7","article-title":"Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers","volume":"17","author":"Venkataprasad","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5173(02)00079-0","article-title":"Coating of cationized protein on engineered nanoparticles results in enhanced immune responses","volume":"238","author":"Cui","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2004.09.014_bib54","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.vaccine.2003.10.035","article-title":"A single vaccination with protein-microspheres elicits a strong CD8 T-cell-mediated immune response against Mycobacterium tuberculosis antigen Mtb8.4","volume":"22","author":"Evans","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1472-9792(02)00080-X","article-title":"Prospects for a better vaccine against tuberculosis","volume":"83","author":"Reed","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jconrel.2004.09.014_bib56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/14712598.4.7.1129","article-title":"Taking a toll on human disease: toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents","volume":"4","author":"Baldridge","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2004.09.014_bib57","first-page":"16","article-title":"New advances in vaccine delivery systems","volume":"30","author":"Eldridge","year":"1993","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/314828","article-title":"Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens","volume":"180","author":"Couillin","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2004.09.014_bib59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1440-1746.2002.02652.x","article-title":"Therapeutic vaccination in chronic hepatitis B","volume":"17","author":"Senturk","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib60","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0168-8278(01)00028-9","article-title":"Efficacy and limitations of a specific immunotherapy in chronic hepatitis B","volume":"34","author":"Pol","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/JVI.72.1.84-94.1998","article-title":"Protective efficacy of DNA vaccines against duck hepatitis B virus infection","volume":"72","author":"Triyatni","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0264-410X(02)00575-3","article-title":"Progress in DNA vaccine for prophylaxis and therapy of hepatitis B","volume":"21","author":"Thermet","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2004.09.014_bib63","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.4049\/jimmunol.156.10.3687","article-title":"DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice","volume":"156","author":"Kuhober","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib64","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.162.5.3088","article-title":"Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans","volume":"162","author":"Livingston","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib65","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.4049\/jimmunol.171.10.4984","article-title":"Cutting edge: different toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos","volume":"171","author":"Agrawal","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib66","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.171.8.4320","article-title":"Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses","volume":"171","author":"Lore","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib67","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2004.09.014_bib68","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","article-title":"Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells","volume":"299","author":"Pasare","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2004.09.014_bib69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1567201043334597","article-title":"Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery","volume":"1","author":"Diwan","year":"2004","journal-title":"Curr. Drug Deliv."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836590400464X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836590400464X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T20:06:18Z","timestamp":1682885178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836590400464X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S016836590400464X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2004.09.014","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}